Christopher Causey, Director at UNITED THERAPEUTICS Corp (UTHR), sold 1,160 shares at $134.72 ($156K) on 2017-12-07, disclosed to the SEC on 2017-12-07.
Seasonal sale ($156k) by Director — this insider has traded UTHR in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $134.72 | 580 | $78K | 50.0% |
| 2 | $134.72 | 580 | $78K | 50.0% |
| Total | $134.72 avg | 1,160 | $156K | 100% |
| Filing → |
| UTHR | SELL | 2026-02-25 | $520K | — | Filing → |
| UTHR | SELL | 2026-01-06 | $510K | — | Filing → |
| UTHR | SELL | 2026-01-05 | $500K | — | Filing → |